Proficio Capital Partners LLC Invests $358,000 in Envista Holdings Co. (NYSE:NVST)

Proficio Capital Partners LLC acquired a new position in Envista Holdings Co. (NYSE:NVST) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 18,576 shares of the company’s stock, valued at approximately $358,000.

Several other large investors also recently added to or reduced their stakes in the business. M&T Bank Corp increased its holdings in shares of Envista by 4.2% in the 4th quarter. M&T Bank Corp now owns 16,621 shares of the company’s stock worth $320,000 after buying an additional 676 shares during the last quarter. Assetmark Inc. grew its position in Envista by 2.5% in the fourth quarter. Assetmark Inc. now owns 39,624 shares of the company’s stock worth $764,000 after acquiring an additional 983 shares in the last quarter. Keybank National Association OH bought a new position in Envista in the fourth quarter valued at $234,000. Charles Schwab Investment Management Inc. raised its position in Envista by 8.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,317,631 shares of the company’s stock valued at $44,707,000 after purchasing an additional 179,600 shares in the last quarter. Finally, US Bancorp DE lifted its stake in Envista by 340.9% during the fourth quarter. US Bancorp DE now owns 21,919 shares of the company’s stock worth $423,000 after purchasing an additional 16,948 shares during the last quarter.

Envista Price Performance

Shares of NVST stock opened at $17.44 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $23.00. The firm has a market cap of $3.00 billion, a P/E ratio of -2.69, a P/E/G ratio of 1.27 and a beta of 1.33. The business’s 50 day moving average price is $19.70 and its 200-day moving average price is $19.61.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, equities research analysts anticipate that Envista Holdings Co. will post 1 earnings per share for the current year.

Wall Street Analyst Weigh In

NVST has been the topic of a number of research reports. Mizuho assumed coverage on Envista in a report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price objective on the stock. Piper Sandler boosted their price objective on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday, February 3rd. Morgan Stanley reduced their target price on shares of Envista from $20.00 to $19.00 and set an “equal weight” rating on the stock in a report on Thursday, March 6th. Jefferies Financial Group boosted their price target on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Finally, New Street Research set a $19.00 price objective on Envista in a report on Thursday, March 6th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $20.18.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.